Cargando…

Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC

Background and Aims: The ghrelin receptor is one of the new therapeutic targets in the cancer anorexia-cachexia syndrome. Previous studies revealed that plasma ghrelin levels were high in patients with anorexia nervosa and low in obese subjects. We studied to what extent ghrelin levels are related w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blauwhoff-Buskermolen, Susanne, Langius, Jacqueline A. E., Heijboer, Annemieke C., Becker, Annemarie, de van der Schueren, Marian A. E., Verheul, Henk M. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331052/ https://www.ncbi.nlm.nih.gov/pubmed/28298897 http://dx.doi.org/10.3389/fphys.2017.00119

Ejemplares similares

The influence of different muscle mass measurements on the diagnosis of cancer cachexia
por: Blauwhoff‐Buskermolen, Susanne, et al.
Publicado: (2017)

Reply to L.E. Daly et al
por: Blauwhoff-Buskermolen, Susanne, et al.
Publicado: (2016)

The effect of individualized NUTritional counseling on muscle mass and treatment outcome in patients with metastatic COLOrectal cancer undergoing chemotherapy: a randomized controlled trial protocol
por: van der Werf, Anne, et al.
Publicado: (2015)

The assessment of anorexia in patients with cancer: cut-off values for the FAACT–A/CS and the VAS for appetite
por: Blauwhoff-Buskermolen, S., et al.
Publicado: (2015)

Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014)

Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
por: Fujitsuka, N, et al.
Publicado: (2011)

Muscle mass as a target to reduce fatigue in patients with advanced cancer
por: Neefjes, Elisabeth C.W., et al.
Publicado: (2017)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population
por: van der Werf, A., et al.
Publicado: (2017)

Pathophysiology of anorexia in the cancer cachexia syndrome
por: Ezeoke, Chukwuemeka Charles, et al.
Publicado: (2015)

Chronic Renal Failure, Cachexia, and Ghrelin
por: Laviano, A., et al.
Publicado: (2010)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

The Role of Ghrelin in Anorexia Nervosa
por: Schalla, Martha A., et al.
Publicado: (2018)

Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006)

Leptin in Anorexia and Cachexia Syndrome
por: Engineer, Diana R., et al.
Publicado: (2012)

Cachexia-anorexia in cancer patients
Publicado: (1996)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

Natural ghrelin in advanced cancer patients with cachexia, a case series
por: Blum, David, et al.
Publicado: (2021)

Effects of different training modalities on phosphate homeostasis and local vitamin D metabolism in rat bone
por: Buskermolen, Joost, et al.
Publicado: (2019)

Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
por: T. de Barros, Cecilia, et al.
Publicado: (2020)

Ghrelin: Central and Peripheral Implications in Anorexia Nervosa
por: Méquinion, Mathieu, et al.
Publicado: (2013)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
por: Strasser, F, et al.
Publicado: (2008)

Pancreatic cancer cachexia: a review of mechanisms and therapeutics
por: Tan, Carlyn R., et al.
Publicado: (2014)

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
por: Müller, Timo D., et al.
Publicado: (2010)

Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
por: Peixoto da Silva, Sara, et al.
Publicado: (2020)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia
por: VanderVeen, Brandon N., et al.
Publicado: (2020)

Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia
por: Morley, John E.
Publicado: (2017)

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2017)

Leptin and ghrelin expressions in the gastrointestinal tracts of calves and cows
por: HAYASHI, Hideaki, et al.
Publicado: (2020)

The Skeletal Muscle as an Active Player Against Cancer Cachexia
por: Penna, Fabio, et al.
Publicado: (2019)

Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia
por: François, Marie, et al.
Publicado: (2016)

The role of dysregulated ghrelin/LEAP-2 balance in anorexia nervosa
por: Tezenas du Montcel, Chloé, et al.
Publicado: (2023)

Acylation, a Conductor of Ghrelin Function in Brain Health and Disease
por: Thomas, Alanna S., et al.
Publicado: (2022)

Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)

Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis
por: Archid, Rami, et al.
Publicado: (2019)

Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
por: Yeom, Eunbyul, et al.
Publicado: (2022)

Exercise in People With Cancer: A Spotlight on Energy Regulation and Cachexia
por: Allan, Jessica, et al.
Publicado: (2022)

Muscle metabolic stress determines cancer cachexia severity in mice
por: Alves, Christiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4rb81fdsj72g83gsnb3knned2